Prince of Wales Hospital, Sydney
13
2
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
31%
4 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer
Role: collaborator
Trial of Arm Sleeve and Forearm Fatigue During Robotic Surgery
Role: lead
Patient Experience and Acceptance of Horizontal Rotation
Role: collaborator
AusCADASIL: An Australian Cohort of CADASIL
Role: collaborator
Suture-Tight™ First-in-Human Safety and Performance Study
Role: collaborator
Day/Night Regimen With Provox Life Heat and Moisture Exchangers
Role: collaborator
Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
Role: collaborator
Early Intensive Hand Rehabilitation After Spinal Cord Injury
Role: collaborator
SCIPA Full-On :Intensive Exercise Program After Spinal Cord Injury
Role: collaborator
Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms
Role: collaborator
Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
Role: collaborator
Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
Role: collaborator
Malnutrition Screening in Acute Aged Care
Role: lead
All 13 trials loaded